Article
Genotype, viral load and age as independent predictors of treatment outcome of interferon-alpha 2a treatment in patients with chronic hepatitis C. Construct group.
Scandinavian journal of infectious diseases - 1 Jan 1997
Bell H, Hellum K, Harthug S, Maeland A, Ritland S, Myrvang B, von der Lippe B, Raknerud N, Skaug K, Gutigard B G, Skjaerven R, Prescott L E, Simmonds P
Abstract excerpt
Patients with chronic hepatitis C respond differently when treated with interferon. We randomized 116 patients with chronic hepatitis C in order to compare two dosage regimens of recombinant interferon alpha 2a:3 MIU x 3 per week for 6 months (arm A) or 6 MIU x 3 per week for 3 months and then 3...
Topics
- Age Factors
- Alanine Transaminase
- Antiviral Agents
- Chi-Square Distribution
- Chronic Disease
- Female
- Genotype
- Hepacivirus
- Hepatitis C
- Humans
- Interferon alpha-2
- Interferon-alpha
- Liver
- Logistic Models